Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Sep;27(9):1343-1347.
doi: 10.1002/lt.25981. Epub 2021 Mar 15.

Cirrhosis Is Associated With High Mortality and Readmissions Over 90 Days Regardless of COVID-19: A Multicenter Cohort

Jasmohan S Bajaj  1   2 , Guadalupe Garcia-Tsao  3 , Florence Wong  4 , Scott W Biggins  5 , Patrick S Kamath  6 , Sara McGeorge  1 , Michael Chew  3 , Meredith Pearson  5 , Jawaid Shaw  1   2 , Anita Kalluri  7 , Andrew Fagan  2 , Amy Olofson  6 , Maryam Moini  4 , Randolph de la Rosa Rodriguez  3 , K Rajender Reddy  7
Affiliations
Multicenter Study

Cirrhosis Is Associated With High Mortality and Readmissions Over 90 Days Regardless of COVID-19: A Multicenter Cohort

Jasmohan S Bajaj et al. Liver Transpl. 2021 Sep.
No abstract available

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
(A) Flowchart of patients from the inception to follow‐up. (B) All‐cause readmission rates between groups showed similar rates within the cirrhosis groups, which was significantly higher than the patients with COVID‐19 only (comparison using chi‐square test). (C) In the patients with cirrhosis who experienced a readmission, the proportion who were readmitted as a result of liver‐related conditions was higher in the cirrhosis‐only group versus the cirrhosis + COVID‐19 group (comparison using chi‐square test). (D) In the patients with COVID‐19 who experienced a readmission, the proportion who were readmitted as a result of COVID‐19–related conditions was statistically similar (comparison using Fisher’s exact test).
See this image and copyright information in PMC

References

    1. COVID‐19 and CDC . https://www.cdc.gov/coronavirus/2019‐ncov/need‐extra‐precautions/people‐.... Accessed December 21, 2020.
    1. Bajaj JS, Garcia‐Tsao G, Biggins S, Kamath PS, Wong F, McGeorge S, et al. Comparison of mortality risk in patients with cirrhosis and COVID‐19 compared with patients with cirrhosis alone and COVID‐19 alone: multicentre matched cohort. Gut 2020. 10.1136/gutjnl-2020-322118. - DOI - PMC - PubMed
    1. Mahmud N, Hubbard RA, Kaplan DE, Serper M. Declining cirrhosis hospitalizations in the wake of the COVID‐19 pandemic: a national cohort study. Gastroenterology 2020;159:1134‐1136.e3. - PMC - PubMed
    1. O'Leary JG, Reddy KR, Garcia‐Tsao G, Biggins SW, Wong F, Fallon MB, et al. NACSELD Acute‐on‐Chronic Liver Failure (NACSELD‐ACLF) score predicts 30‐day survival in hospitalized patients with cirrhosis. Hepatology 2018;67:2367‐2374. - PubMed
    1. AASLD Guidance on COVID‐19 . https://www.aasld.org/sites/default/files/2020‐06/AASLD‐COVID19‐ExpertPa.... Accessed December 21, 2020.

Publication types